Your browser doesn't support javascript.
loading
Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again?
Barrett, Christopher D; Neal, Matthew D; Schoenecker, Jonathan G; Medcalf, Robert L; Myles, Paul S.
Afiliação
  • Barrett CD; Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Neal MD; Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Schoenecker JG; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Medcalf RL; Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Myles PS; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Transfusion ; 64 Suppl 2: S11-S13, 2024 May.
Article em En | MEDLINE | ID: mdl-38461482
ABSTRACT
Tranexamic acid (TXA) has proven mortality benefit if used early after traumatic injury, likely related to a combination of bleeding reduction and other non-bleeding effects. If TXA is given more than 3 h after traumatic injury, there is a significant and paradoxical increased risk of death due to bleeding. TXA has level 1 evidence for use as a bleeding reduction agent in isolated orthopedic operations, but in polytrauma patients undergoing orthopedic operations, it is not clear if and when TXA is safe or effective once outside the 3-h window of proven trauma efficacy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Ferimentos e Lesões / Hemorragia / Antifibrinolíticos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Ferimentos e Lesões / Hemorragia / Antifibrinolíticos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article